New Law Requiring Emergency Insulin and Diabetes Prescription Supplies Taking Effect Jan. 1 - NBC Connecticut
Connecticut will require pharmacies to stock emergency insulin and diabetes supplies starting Jan. 1, 2025.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on July 28, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. All Connecticut pharmacies, including independent, retail chain, compounding, and long-term-care pharmacies. should confirm how it applies to their specific situation before acting. There is a time constraint attached: January 1, 2025. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
New law mandates pharmacies to maintain a supply of emergency insulin and diabetes prescription supplies for patients in urgent need.
Who it affects
All Connecticut pharmacies, including independent, retail chain, compounding, and long-term-care pharmacies.
What you must do
Ensure adequate stock of emergency insulin and diabetes supplies, update inventory protocols, and train staff on dispensing procedures.
Deadline
January 1, 2025
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- Pharmacy technicians must register with Florida's Board of Pharmacy by Jan. 1, 2010 - Drug Topics
- Judge Trims DEA's Suspension Of Fla. Pharmacy's Permits - Law360
- New Wisconsin Law Regulates PBM and Other Stakeholders Involved in Drug Pricing - Quarles
- Pharmacists in WV can now give COVID-19 vaccines without prescriptions - Charleston Gazette-Mail
- What Does DEA’s Proposed Special Registration Framework for Tele-prescribing Controlled Substances Mean? - Reed Smith LLP